美国十家医疗机构2023-2024年度孕期COVID-19疫苗接种覆盖率
本研究基于疫苗安全数据链(VSD)十家医疗机构,评估2023年9月至2024年8月期间167,478名18-49岁孕妇接种2023-2024年度COVID-19疫苗的情况,发现仅14.3%(23,941人)在孕前或孕期接种。接种覆盖率随年龄组和孕期医疗利用增加而升高,且因种族/民族和妊娠开始月份而异。该人群接种率低,VSD将继续监测2024-2025年度接种覆盖率。
要点
- 2023-2024年度COVID-19疫苗孕期接种率为14.3%。
- 接种率随年龄组升高(4.8%-21.2%)和孕期医疗利用增加(9.8%-17.6%)而上升。
- 不同种族/民族(7.2%-23.2%)和妊娠开始月份(1.3%-17.6%)接种率存在差异。
核心结论
- 2023-2024年度COVID-19疫苗在孕期人群中接种率低,仅14.3%。
研究设计与样本
- 基于疫苗安全数据链(VSD)十家医疗机构的回顾性队列研究,纳入167,478名18-49岁孕妇,孕期覆盖2023年9月至2024年8月。
主要发现
- 23,941名(14.3%)孕妇在孕前或孕期接种了2023-2024年度COVID-19疫苗。
- 接种覆盖率随年龄组升高而增加,范围4.8%至21.2%。
- 接种覆盖率随孕期医疗利用增加而升高,范围9.8%至17.6%。
- 接种覆盖率因母亲种族和民族而异,范围7.2%至23.2%。
- 接种覆盖率因妊娠开始日历月份而异,范围1.3%至17.6%。
关键数值与推荐
- 2023-2024年度COVID-19疫苗孕期接种率为14.3%(23,941/167,478)。
- 年龄组接种率范围4.8%-21.2%,医疗利用组范围9.8%-17.6%,种族/民族组范围7.2%-23.2%,妊娠开始月份组范围1.3%-17.6%。
临床怎么用
- 提示需针对孕期人群,尤其是年轻、医疗利用少及特定种族/民族和妊娠月份人群,加强COVID-19疫苗接种宣传与推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Data on COVID-19 vaccination coverage in pregnancy are sparse, with most literature focused on original monovalent and bivalent vaccines. We assessed coverage of 2023-2024 COVID-19 vaccines among pregnant women across ten health care organizations in the United States participating in the Vaccine Safety Datalink (VSD). Among 167,478 women aged 18-49 years with a pregnancy during September 2023-August 2024, 23,941 (14.3%) received a 2023-2024 COVID-19 vaccine dose prior to or during their pregnancy. We identified higher coverage with increasing age groups (range 4.8% to 21.2% vaccinated) and increasing healthcare utilization during pregnancy (range 9.8% to 17.6% vaccinated). We found differences in coverage by maternal race and ethnicity (range 7.2% to 23.2% vaccinated), and by calendar month of pregnancy start (range 1.3% to 17.6% vaccinated). Uptake of 2023-2024 COVID-19 vaccines was low in this population. The VSD will continue monitoring COVID-19 vaccination coverage in pregnancy in the 2024-2025 season, including coverage by maternal race and ethnicity.
引用
- Irving SA, Crane B, Daley MF, et al. 2023-2024 COVID-19 vaccination coverage in pregnancy in ten healthcare delivery organizations in the United States. Vaccine. 2026. PMID: 41825191. doi:10.1016/j.vaccine.2026.128441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。